z-logo
Premium
Metastasectomy, intralesional resection, or stabilization only in the treatment of bone metastases from renal cell carcinoma
Author(s) -
Langerhuizen David W.G.,
Janssen Stein J.,
van der Vliet Quirine M.J.,
Raskin Kevin A.,
Ferrone Marco L.,
Hornicek Francis J.,
Schwab Joseph H.,
LozanoCalderón Santiago A.
Publication year - 2016
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.24284
Subject(s) - medicine , metastasectomy , curettage , renal cell carcinoma , surgery , surgical margin , survival rate , metastasis , overall survival , retrospective cohort study , significant difference , urology , resection , oncology , cancer
Background The mainstay of treatment for bone metastases from renal cell carcinoma is surgery. We assessed if there was a difference in local recurrence, reoperation, and survival between patients who underwent metastasectomy, intralesional curettage, or stabilization only for renal cell carcinoma metastasis to the appendicular skeleton, and if there was a difference in these outcomes based on margin status. Methods This retrospective study included 183 patients; 48% underwent metastasectomy (n = 88, margins: 64 negative; 20 positive; 4 unclear), 30% intralesional curettage (n = 54), and 22% stabilization only (n = 41). Results The recurrence rate differed and was highest after stabilization only (39%), followed by intralesional curettage (22%), and metastasectomy (12%) ( P  = 0.003). However, we found no difference in reoperation rate ( P  = 0.847). Survival was better in patients who underwent metastasectomy ( P  = 0.020). The recurrence rate was lower in patients who had a negative margin (5%) as compared to those with a positive margin (26%) ( P  < 0.001). However, we found no difference in reoperation rate ( P  = 0.97). Negative margins showed better survival ( P  < 0.001). Conclusions Our findings emphasize the importance of obtaining negative margins in patients with a good life expectancy, as lower recurrence rate can be attained at a not significant additional risk for reoperation, with a potential impact on survival. J. Surg. Oncol. 2016;114:237–245 . © 2016 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom